What do the latest data tell us about the European drug market? What are the new trends in drug use among European adults and school students? What are the harms associated with drug use and what is being done to counter them? These and other questions will be explored by the EU drugs agency (EMCDDA) on 6 June in its annual overview of the European drug situation. The European Drug Report 2017: Trends and Developments, provides a comprehensive analysis of the latest tendencies across the 28 EU Member States, Turkey and Norway. In print and pdf in 24 languages, the report examines: drug supply and the market; drug use prevalence and trends; and drug-related harms and responses to them. Accompanying the report will be the 2017 Statistical Bulletin, containing the European dataset underpinning the analysis.
Originally published in: